Haefeli WE - Search Results

1

The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis.

Meid AD, Lampert A, Burnett A, Seidling HM, Haefeli WE. Meid AD, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2015 Oct;80(4):768-76. doi: 10.1111/bcp.12657. Epub 2015 Jun 12. Br J Clin Pharmacol. 2015. PMID: 25868941 Free PMC article. Review.

2

Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

Martin-Facklam M, Burhenne J, Ding R, Fricker R, Mikus G, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2002 Jun;53(6):576-81. doi: 10.1046/j.1365-2125.2002.01595.x. Br J Clin Pharmacol. 2002. PMID: 12047481 Free PMC article. Clinical Trial.

3

Quality of drug information on the World Wide Web and strategies to improve pages with poor information quality. An intervention study on pages about sildenafil.

Martin-Facklam M, Kostrzewa M, Martin P, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2004 Jan;57(1):80-5. doi: 10.1046/j.1365-2125.2003.01954.x. Br J Clin Pharmacol. 2004. PMID: 14678344 Free PMC article. Clinical Trial.

4

High prevalence of unknown co-medication in hospitalised patients.

Rieger K, Scholer A, Arnet I, Peters FT, Maurer HH, Walter-Sack I, Haefeli WE, Martin-Facklam M. Rieger K, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2004 Jul;60(5):363-8. doi: 10.1007/s00228-004-0784-6. Epub 2004 Jun 10. Eur J Clin Pharmacol. 2004. PMID: 15197522

5

Drug interactions in primary care: impact of a new algorithm on risk determination.

Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE. Bergk V, et al. Among authors: haefeli we. Clin Pharmacol Ther. 2004 Jul;76(1):85-96. doi: 10.1016/j.clpt.2004.02.009. Clin Pharmacol Ther. 2004. PMID: 15229467

6

Undeclared exposure to St. John's Wort in hospitalized patients.

Martin-Facklam M, Rieger K, Riedel KD, Burhenne J, Walter-Sack I, Haefeli WE. Martin-Facklam M, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2004 Oct;58(4):437-41. doi: 10.1111/j.1365-2125.2004.02169.x. Br J Clin Pharmacol. 2004. PMID: 15373938 Free PMC article.

7

Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individuals.

Hesse C, Luntz SP, Siedler H, Unnebrink K, Mikus G, de Bruijn M, Zondag E, de Vries M, Seibert-Grafe M, Haefeli WE. Hesse C, et al. Among authors: haefeli we. Br J Clin Pharmacol. 2006 Apr;61(4):414-9. doi: 10.1111/j.1365-2125.2006.02590.x. Br J Clin Pharmacol. 2006. PMID: 16542202 Free PMC article. Clinical Trial.

8

The frequency of inappropriate tablet splitting in primary care.

Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. Quinzler R, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2006 Dec;62(12):1065-73. doi: 10.1007/s00228-006-0202-3. Epub 2006 Oct 6. Eur J Clin Pharmacol. 2006. PMID: 17024485

9

Detection and prevention of prescriptions with excessive doses in electronic prescribing systems.

Seidling HM, Al Barmawi A, Kaltschmidt J, Bertsche T, Pruszydlo MG, Haefeli WE. Seidling HM, et al. Among authors: haefeli we. Eur J Clin Pharmacol. 2007 Dec;63(12):1185-92. doi: 10.1007/s00228-007-0370-9. Epub 2007 Sep 5. Eur J Clin Pharmacol. 2007. PMID: 17786416

10

CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.

Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, Haefeli WE, Mikus G. Weiss J, et al. Among authors: haefeli we. J Clin Pharmacol. 2009 Feb;49(2):196-204. doi: 10.1177/0091270008327537. Epub 2008 Nov 25. J Clin Pharmacol. 2009. PMID: 19033450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page